DEVELOPMENT OF "GLYCEMIC CONTROL BAR WITH BEANS AND TOMATO FOR DIABETIC EATING" (GLYCOBITE) SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS
The GlycoBite snack bar, developed by University Ngudi Waluyo, targets the growing market of functional foods for diabetes management. With the increasing prevalence of Type 2 Diabetes Mellitus (T2DM), the demand for healthy snack options is on the rise. This trial aims to establish the GlycoBite's effectiveness in improving glycemic control, potentially positioning it as a competitive alternative to existing commercial snack bars. The study's outcomes could influence market entry strategies and partnerships with health-focused food manufacturers. Additionally, the trial's findings may attract interest from investors and stakeholders in the health and wellness sector, particularly those focused on diabetes care.
Indication: Diabetes Mellitus
Modality: combination therapy
Target: Glycemic control through dietary intervention using a snack bar formulation combining red beans and tomatoes.
Sponsor: University Ngudi Waluyo
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 03, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Glycemic control through dietary intervention using a snack bar formulation combining red beans and tomatoes.
View original source fields
Condition raw: Diabetes Mellitus
Condition normalized: Diabetes Mellitus
Modality raw: combination therapy
Modality normalized: combination therapy
Target raw: Glycemic control through dietary intervention using a snack bar formulation combining red beans and tomatoes.
Target normalized: Glycemic control through dietary intervention using a snack bar formulation combining red beans and tomatoes.